Approval · Notice of Compliance 2916 · 1998
ANSAID: Notice of Compliance 2916
Issued May 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2916
- Date
- May 4, 1998
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-inflammatory, analgesic agent
Products in this notice
Medicinal ingredients
- FLURBIPROFEN 50 MG per TAB
- FLURBIPROFEN 100 MG per TAB